[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2009125936A3 - Analysis method and kit for diagnosis of polycystic ovary syndrome - Google Patents

Analysis method and kit for diagnosis of polycystic ovary syndrome Download PDF

Info

Publication number
WO2009125936A3
WO2009125936A3 PCT/KR2009/001614 KR2009001614W WO2009125936A3 WO 2009125936 A3 WO2009125936 A3 WO 2009125936A3 KR 2009001614 W KR2009001614 W KR 2009001614W WO 2009125936 A3 WO2009125936 A3 WO 2009125936A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
polycystic ovary
ovary syndrome
kit
analysis method
Prior art date
Application number
PCT/KR2009/001614
Other languages
French (fr)
Korean (ko)
Other versions
WO2009125936A2 (en
Inventor
백광현
김명선
김용수
Original Assignee
포천중문의과대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 포천중문의과대학교 산학협력단 filed Critical 포천중문의과대학교 산학협력단
Publication of WO2009125936A2 publication Critical patent/WO2009125936A2/en
Publication of WO2009125936A3 publication Critical patent/WO2009125936A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2561/00—Nucleic acid detection characterised by assay method
    • C12Q2561/113—Real time assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to an analysis method including a step of measuring the amount of gene expression for coding one or more proteins selected from a group consisting of proteins of sequence numbers 1 to 4 in a patient specimen to provide information required for diagnosis of polycystic ovary syndrome. The present invention further relates to a kit for the diagnosis of polycystic ovary syndrome including a reagent for measuring the amount of gene expression for coding one or more proteins selected from a group consisting of proteins of sequence numbers 1 to 4.
PCT/KR2009/001614 2008-04-11 2009-03-30 Analysis method and kit for diagnosis of polycystic ovary syndrome WO2009125936A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080033768A KR20090108378A (en) 2008-04-11 2008-04-11 Analytical method for diagnosing polycystic ovary syndrome and kit therefor
KR10-2008-0033768 2008-04-11

Publications (2)

Publication Number Publication Date
WO2009125936A2 WO2009125936A2 (en) 2009-10-15
WO2009125936A3 true WO2009125936A3 (en) 2009-12-30

Family

ID=41162363

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/001614 WO2009125936A2 (en) 2008-04-11 2009-03-30 Analysis method and kit for diagnosis of polycystic ovary syndrome

Country Status (2)

Country Link
KR (1) KR20090108378A (en)
WO (1) WO2009125936A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101450138B1 (en) * 2013-01-25 2014-10-13 순천향대학교 산학협력단 Marker and Kit for Diagnosis of Polycystic Ovary syndrom
US10249040B2 (en) 2016-11-21 2019-04-02 International Business Machines Corporation Digital data processing for diagnosis of a subject
US10123747B2 (en) 2016-11-21 2018-11-13 International Business Machines Corporation Retinal scan processing for diagnosis of a subject
US10398385B2 (en) 2016-11-21 2019-09-03 International Business Machines Corporation Brain wave processing for diagnosis of a subject
US10127664B2 (en) 2016-11-21 2018-11-13 International Business Machines Corporation Ovarian image processing for diagnosis of a subject

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116247A1 (en) * 2004-05-27 2005-12-08 Neocodex Method and device for the in vitro detection of polycystic ovarian syndrome (pcos) and pathologies involving cardiovascular risk
US20060068387A1 (en) * 2002-04-22 2006-03-30 Northwestern University Genetic marker for endocrine disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060068387A1 (en) * 2002-04-22 2006-03-30 Northwestern University Genetic marker for endocrine disorders
WO2005116247A1 (en) * 2004-05-27 2005-12-08 Neocodex Method and device for the in vitro detection of polycystic ovarian syndrome (pcos) and pathologies involving cardiovascular risk

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CORTON, M. ET AL.: "Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry.", HUM. REPROD., vol. 23, no. 3, 22 December 2007 (2007-12-22), pages 651 - 661 *
MA, X. ET AL.: "Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome.", MOL. HUM. REPROD., vol. 13, no. 8, 7 June 2007 (2007-06-07), pages 527 - 535 *
MATHAROO-BALL,B. ET AL.: "Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms.", J. PROTEOME. RES., vol. 6, no. 8, 29 June 2007 (2007-06-29), pages 3321 - 3328 *

Also Published As

Publication number Publication date
KR20090108378A (en) 2009-10-15
WO2009125936A2 (en) 2009-10-15

Similar Documents

Publication Publication Date Title
TW200745556A (en) Biomarkers for liver fibrotic injury
WO2008021290A8 (en) Organ-specific proteins and methods of their use
WO2008064067A3 (en) Method for the sequential analysis of different components in a single biological sample and reagents therefor
ATE525482T1 (en) NANOREPORTERS AND METHOD FOR THE PRODUCTION AND USE THEREOF
WO2010041892A3 (en) Novel application of aimp1 polypeptide
ATE548467T1 (en) METHOD FOR IDENTIFYING BIOMARKERS USEFUL IN DIAGNOSING BIOLOGICAL CONDITIONS
WO2010090471A3 (en) Novel diagnostic marker for type 1 diabetes mellitus
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
WO2007136980A3 (en) Diagnostic test media and methods for the manufacture thereof
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
WO2007114986A3 (en) Cooperative probes and methods of using them
EP2021794B8 (en) Use of protein s100a 12 as a marker for colorectal cancer
EP2021512A4 (en) Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets
EP1930445A4 (en) Kit and method for detection of urothelial cancer
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2009125936A3 (en) Analysis method and kit for diagnosis of polycystic ovary syndrome
WO2010035140A8 (en) Method for analyzing d4z4 tandem repeat arrays of nucleic acid and kit therefore
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
DE602007009498D1 (en) NEW FLUORESCENCE PROTEINS AND METHOD FOR USE THEREOF
WO2010127417A3 (en) Hepatocellular carcinoma
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
WO2008072275A3 (en) Telematic system for using diagnostic reagent strips and method for acquiring calibration data
WO2012135620A8 (en) Molecular gram stain

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09730466

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09730466

Country of ref document: EP

Kind code of ref document: A2